2020
DOI: 10.1136/vr.105937
|View full text |Cite
|
Sign up to set email alerts
|

Investigating the presence of equine piroplasmosis in Ireland

Abstract: BackgroundEquine piroplasmosis (EP) is a notifiable disease in Ireland and a significant concern to domestic and international equine industries. Information regarding EP presence in Ireland is currently limited. This retrospective surveillance study describes a serological and molecular analysis of blood samples submitted to the Irish Equine Centre for EP testing between January 2013 and April 2016.MethodsFollowing serological testing, seropositive samples were screened using a PCR targeting the 18S ribosomal… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 7 publications
(12 citation statements)
references
References 34 publications
(40 reference statements)
2
7
0
Order By: Relevance
“…These seroprevalences are considerably higher than our observations, while both studies make use of samples submitted for routine diagnostics in the context of export, and are more in the line of the seroprevalence reported in Switzerland (7.3%) ( 22 ). A similar study with samples submitted for screening in Ireland showed an overall seroprevalence of 3.5% (1.5% for B. caballi and 2.5% for T. equi ) which is more comparable to the seroprevalences found in our study compared to the seroprevalence of 8.0% in the UK ( 23 ). Due to legislation concerning data protection, no detailed information was available on the origin of the tested horses ( 23 ).…”
Section: Discussionsupporting
confidence: 86%
See 1 more Smart Citation
“…These seroprevalences are considerably higher than our observations, while both studies make use of samples submitted for routine diagnostics in the context of export, and are more in the line of the seroprevalence reported in Switzerland (7.3%) ( 22 ). A similar study with samples submitted for screening in Ireland showed an overall seroprevalence of 3.5% (1.5% for B. caballi and 2.5% for T. equi ) which is more comparable to the seroprevalences found in our study compared to the seroprevalence of 8.0% in the UK ( 23 ). Due to legislation concerning data protection, no detailed information was available on the origin of the tested horses ( 23 ).…”
Section: Discussionsupporting
confidence: 86%
“…A similar study with samples submitted for screening in Ireland showed an overall seroprevalence of 3.5% (1.5% for B. caballi and 2.5% for T. equi ) which is more comparable to the seroprevalences found in our study compared to the seroprevalence of 8.0% in the UK ( 23 ). Due to legislation concerning data protection, no detailed information was available on the origin of the tested horses ( 23 ). However, the seroprevalence is still at least twice as high as the seroprevalences in both Dutch horses and horses originating from abroad in our study.…”
Section: Discussionsupporting
confidence: 86%
“…Regarding United Kingdom, two studies reported a 6.8% seroprevalence for B. caballi and T. equi (Joyner et al., 1981), and 5.9% for T. equi and 4.4% for B. caballi (Coultous et al., 2019). Another recent study reported a seroprevalence of 2.5 % for T. equi and 1 % for B. caballi in Ireland (Coultous et al., 2020). However, these studies were not included in our meta‐analysis due to lack of data regarding the clinical status of the equids and/or the exact origin of the samples tested.…”
Section: Discussionmentioning
confidence: 99%
“…caballi in Ireland (Coultous et al, 2020). However, these studies were not included in our meta-analysis due to lack of data regarding the clinical status of the equids and/or the exact origin of the samples tested.…”
Section: Discussionmentioning
confidence: 99%
“…Past work has found that the Camargue is a hyperendemic area for EP, where the seroprevalence of T. equi and B. caballi infection in horses has been estimated at 58% and 12.9%, respectively (Guidi et al 2015 ). Only a few studies have used PCR to assess the piroplasms’ prevalence in horses and/or ticks in Europe, including in the Mediterranean Basin; to date, such work has been carried out in Spain, the UK, Ireland, Tunisia, and Israel (Ros-García et al 2013 ; Coultous et al 2019 , 2020 ; Camino et al 2021 ; Tirosh-Levy et al 2021 ). Two other studies conducted in Europe characterised the piroplasms’ prevalence in ticks sampled from different hosts, including horses, in Corsica (Grech-Angelini et al 2020 ) and Italy (Iori et al 2010 ).…”
Section: Introductionmentioning
confidence: 99%